{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:50:32Z","timestamp":1774590632123,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"abstract":"<jats:p>Main pancreatic duct (MPD) dilatation is reported to be a risk factor for pancreatic cancer (PC). Although magnetic resonance cholangiopancreatography (MRCP) and ultrasonographic modalities are valuable for monitoring the pancreas, there is limited information on the efficacy of different imaging modalities in measuring MPD diameter. To improve pancreatic imaging, we developed a specialized ultrasound approach focusing on the pancreas (special pancreatic US). We aimed to examine the correlation between MPD diameter measurements using special pancreatic US versus MRCP. We retrospectively reviewed the clinical data of patients with MPD dilation (\u22652.5\u2009mm) via special pancreatic US used for screening at our institution between January 2020 and October 2022 and included patients who underwent magnetic resonance imaging 2 months before and after pancreatic US. The MPD diameter on MRCP was measured at the pancreatic locus, where the maximum MPD diameter was obtained on special pancreatic US. This study included 96 patients, with a median interval of 8.5 days between the date of special pancreatic US and the date of undergoing MRCP. MPD dilatation and\/or pancreatic cysts were diagnosed in 86 patients, PC in 5 patients, and other diseases in 5 patients. The median MPD diameter, measured using special pancreatic US, was 3.4\u2009mm (interquartile range: 2.9\u20134.9\u2009mm), whereas it was 3.5\u2009mm using MRCP (interquartile range: 2.8\u20134.5\u2009mm). There were strong positive correlations between MPD diameter measured on special pancreatic US and that measured on MRCP (<jats:italic toggle=\"yes\">R<\/jats:italic>\u2005=\u20050.925, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). This study revealed strong positive correlations between the MPD diameter measurements using special pancreatic US and MRCP. MPD diameter measurements from each imaging method can be helpful during follow-up in individuals at a high risk of PC.<\/jats:p>","DOI":"10.1097\/md.0000000000037283","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T21:06:20Z","timestamp":1708722380000},"page":"e37283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Correlation between main pancreatic duct diameter measurements: Special pancreatic ultrasonography versus magnetic resonance cholangiopancreatography"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-8960","authenticated-orcid":false,"given":"Kenji","family":"Ikezawa","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Chagi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakaya","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ohkawa","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","article-title":"Clinical practice guidelines for pancreatic cancer 2022 from the Japan Pancreas Society: a synopsis.","volume":"28","author":"Okusaka","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MPA.0000000000001521","article-title":"Risk factors for pancreatic cancer and the necessity of long-term surveillance in patients with pancreatic cystic lesions.","volume":"49","author":"Yoshioka","year":"2020","journal-title":"Pancreas"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3390\/cancers15143634","article-title":"Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations.","volume":"15","author":"Partyka","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"e31705","DOI":"10.1097\/MD.0000000000031705","article-title":"BRCA2 gene mutation in cancer.","volume":"101","author":"Xie","year":"2022","journal-title":"Med (Baltim)"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1148\/radiol.09090992","article-title":"Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study.","volume":"254","author":"Tanaka","year":"2010","journal-title":"Radiology"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2169\/internalmedicine.3702-19","article-title":"Prevalence rate and predictive factors of pancreatic diseases in cases with pancreatic duct dilatation: a cross-sectional study of a large, healthy Japanese population.","volume":"59","author":"Fujisawa","year":"2020","journal-title":"Intern Med"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges.","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00535-023-02024-4","article-title":"Current status of molecular diagnostic approaches using liquid biopsy.","volume":"58","author":"Takahashi","year":"2023","journal-title":"J Gastroenterol"},{"key":"R9-20250503","first-page":"104814","article-title":"Screening of pancreatic cancer: target population, optimal timing and how?","volume":"84","author":"Waleleng","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review.","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.gastro.2021.10.014","article-title":"Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals.","volume":"162","author":"Overbeek","year":"2022","journal-title":"Gastroenterology"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s10038-023-01153-1","article-title":"Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1\/2 variant carriers in Japan.","volume":"68","author":"Ueki","year":"2023","journal-title":"J Hum Genet"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.giec.2021.08.008","article-title":"Pancreatic cancer surveillance and novel strategies for screening.","volume":"32","author":"Dudley","year":"2022","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","article-title":"Early detection of pancreatic cancer.","volume":"5","author":"Pereira","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.gastro.2021.12.259","article-title":"Surveillance imaging in individuals at high risk for pancreatic cancer: not a ceiling, but rather a floor upon which to build.","volume":"162","author":"Rosenthal","year":"2022","journal-title":"Gastroenterology"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment.","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"e0280403","DOI":"10.1371\/journal.pone.0280403","article-title":"Main pancreatic duct dilatation and pancreatic cysts in relatives and spouses of patients with pancreatic cancer.","volume":"18","author":"Ikezawa","year":"2023","journal-title":"PLoS One"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/cancers13030502","article-title":"Predictive factors for pancreatic cancer and its early detection using special pancreatic ultrasonography in high-risk individuals.","volume":"13","author":"Fukuda","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejrad.2017.03.010","article-title":"Evaluating the ability to detect pancreatic lesions using a special ultrasonography examination focusing on the pancreas.","volume":"91","author":"Nakao","year":"2017","journal-title":"Eur J Radiol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2023.01.032","article-title":"Clinical outcomes of intraductal papillary mucinous neoplasms with dilatation of the main pancreatic duct.","volume":"21","author":"Hamada","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1007\/s00464-022-09854-y","article-title":"Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy.","volume":"37","author":"Martin","year":"2023","journal-title":"Surg Endosc"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.hpb.2020.08.004","article-title":"Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma.","volume":"23","author":"Amini","year":"2021","journal-title":"HPB (Oxford)"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of Neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance.","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.22.00298","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival.","volume":"40","author":"Dbouk","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:32:39Z","timestamp":1746318759000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037283","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}